[Newsmaker] Korea halts use of its only COVID-19 antibody drug Regkirona
Social affairsFeb 23, 2022
South Korea is no longer using Celltrion’s Regkirona, the only COVID-19 antibody drug approved for use in the country, after it was shown to be ineffective against the omicron variant. Omicron now accounts for nearly all new infections here. In a message to reporters Wednesday afternoon, the Korea Disease Control and Prevention Agency said it had stopped supplying Regkirona as of Feb. 18, conf...